Home › Multiple Myeloma › Indiana › Fort Wayne
Multiple Myeloma clinical trials in Fort Wayne, IN
4 studies for Multiple Myeloma are looking for participants at sites in and around Fort Wayne (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant
RecruitingPhase 2/3
- Fort Wayne Medical Oncology And Hematology /ID# 278141, Fort Wayne
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
RecruitingPhase 1
- Fort Wayne Medical Oncology And Hematology /ID# 268179, Fort Wayne
Integrated Cancer Repository for Cancer Research
RecruitingObservational studyHealthy volunteers welcome
- Parkview Research Center, Fort Wayne
A Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Gamunex in Participants With Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma
RecruitingPhase 3
- Study Site 101, Fort Wayne
About Multiple Myeloma
Multiple myeloma is a cancer that begins in plasma cells, a type of white blood cell. Discover symptoms, diagnostic tests, and treatments for myeloma.
More about Multiple Myeloma on MedlinePlus
Multiple Myeloma trials in other cities
- New York City, NY60 studies
- Boston, MA42 studies
- Atlanta, GA41 studies
- Houston, TX38 studies
- Durham, NC37 studies
- Nashville, TN32 studies
- Denver, CO26 studies
- Columbus, OH24 studies
- Rochester, MN24 studies
- Baldwin Park, CA23 studies
- St. Louis, MO23 studies
- Washington, DC22 studies
Other studies in Fort Wayne
- Non-Small Cell Lung Cancer17 studies
- Ovarian Cancer8 studies
- Chronic Lymphocytic Leukemia7 studies
- Breast Cancer7 studies
- Cancer (all types)7 studies
- Metastatic Cancer6 studies
- Lung Cancer6 studies
- Endometrial Cancer5 studies
- Colorectal Cancer4 studies
- Triple-Negative Breast Cancer4 studies
- Bladder Cancer4 studies
- Melanoma4 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.